CMT News & Updates
See the latest news about CMT drug development and read stories from the CMT community that highlight why we must deliver treatments and cures during our lifetime.
Filter by Category
Announcing NODE: A New Shared Home for Peripheral Nerve Research Data
The CMT Research Foundation (CMTRF) is excited to announce the launch of the Neuropathy Open Data Exchange (NODE), a new online tool built to help researchers share, compare, and make…
Read More : Announcing NODE: A New Shared Home for Peripheral Nerve Research Data
WEBINAR: Introducing NODE, a New Shared Data Resource for Peripheral Neuropathy Research
In the era of AI, uncovering the secrets that lay buried beneath mountains of scientific data has never felt more possible. However, peripheral nerve research has long been slowed by…
Read More : WEBINAR: Introducing NODE, a New Shared Data Resource for Peripheral Neuropathy Research
Project Report: A Negative Result Points to the Way Forward in CMT4B
A recent study found that a drug that helps other nerve diseases makes CMT4B1 worse, and figuring out why has opened a more promising path toward treatment, including a possible path forward…
Read More : Project Report: A Negative Result Points to the Way Forward in CMT4B
Taking Aim at CMT1J with a genetic medicine
The CMT Research Foundation, in partnership with the 1J Foundation, has funded a new study at the University of Miami led by Dr. Stephan Züchner to evaluate a newly-identified genetic variant linked to Charcot-Marie-Tooth disease type…
CMT Research Is Moving. Here’s What We’re Working On.
Charcot-Marie-Tooth disease progressively damages the peripheral nerves, causing muscle weakness, loss of sensation, and difficulty walking. There's no approved treatment. That's exactly why the CMT Research Foundation exists, and what we're working to change. We’ve recently been in…
Read More : CMT Research Is Moving. Here’s What We’re Working On.
Project Report: A new way to deliver drugs to nerves in CMT
One of the biggest obstacles in CMT research is not a shortage of potential therapies, but a delivery problem: nerves are extremely difficult to reach through the bloodstream. Dr. Kelly…
Read More : Project Report: A new way to deliver drugs to nerves in CMT
New Study at UC San Diego Aims to Identify Best Genetic Treatment for CMT2A
The CMT Research Foundation has funded a new study at University of California San Diego led by Dr. Uri Manor to build an end-to-end pipeline for finding and validating a genetic treatment for CMT2A. …
Read More : New Study at UC San Diego Aims to Identify Best Genetic Treatment for CMT2A
CMTRF Funds Project to Measure if CMT Treatment is Working
The CMT Research Foundation has funded a new study at Johns Hopkins University to find a blood-based biomarker that could measure whether future CMT treatments are working. The research, targeted at subtype CMT2C, is…
Read More : CMTRF Funds Project to Measure if CMT Treatment is Working
Using AI to Our Advantage: A Breakthrough Tool for Tracking CMT Progression
The CMT Research Foundation has invested in a research project with Dr. Wolfgang Pernice at Columbia University to develop a novel tool for clinical endpoint monitoring of Charcot-Marie-Tooth (CMT) disease…
Read More : Using AI to Our Advantage: A Breakthrough Tool for Tracking CMT Progression
CMT Research Foundation Funds Elpida Therapeutics to Launch Manufacturing of a Gene Therapy Drug for CMT4J
CMT Research Foundation announced they have funded Elpida Therapeutics to launch manufacturing of a gene therapy drug for Charcot-Marie-Tooth disease type 4J. The announcement came at the 2025 Global CMT…
